|
D09.8 |
Carcinoma in situ of other specified sites |
| Billable Code | is a billable ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. |
| GEMS |
| ICD-10-CM D09.8 converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM 234.8 Carcinoma in situ of other specified sites |
| ICD-10-CM D09.8is grouped within Diagnostic Related Group(s) (MS-DRG v30.0) |
| 826 MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MCC
|
| 827 MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH CC
|
| 828 MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITHOUT CC/MCC
|
| 829 MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH CC/MCC
|
| 830 MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITHOUT CC/MCC
|
| 843 OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC
|
| 844 OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC
|
| 845 OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC
|
| Type 1 Excludes |
| carcinoma in situ of endocrine pancreas (D01.7) |
| carcinoma in situ of ovary (D07.39) |
| carcinoma in situ of testis (D07.69) |
